脊髓瘤中lncRNA的致病机制和潜在的临床价值
Yuan Liu1, Hui Yuan1, JingJia Fan1
1Department of Clinical Medicine, School of Clinical Medical, Southwest Medical University, Luzhou, 646000, Sichuan, China.
Discover oncology
|July 5, 2024
概括
长非编码RNAs (lncRNAs) 对质瘤的发展和进展至关重要. 本综述详细介绍了lncRNA失调如何影响结质瘤,强调了它们的临床意义.
科学领域:
- 神经瘤学神经瘤学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 质瘤是最常见的恶性中枢神经系统瘤,其特点是预后不佳.
- 2021年世界卫生组织分类根据组织学和分子特征对质瘤进行了分类.
- 长非编码RNAs (lncRNAs) 是调节细胞过程的非蛋白质编码转录.
研究的目的:
- 审查 lncRNA 失调在质瘤发病和进展中的作用.
- 探索 lncRNAs 对质瘤关键生物过程的影响.
- 总结IncRNAs在质瘤管理中的临床意义.
主要方法:
- 关于lncRNA和质瘤的研究的文献综述.
- 对IncRNA参与质瘤扩散,亡,入侵和迁移的分析.
- 检查lncRNA在血管生成,免疫调节,糖解,干性和药物耐药性中的作用.
主要成果:
- lncRNA失调显著影响着质瘤细胞的增殖和亡.
- 改变的lncRNA表达会影响质瘤的侵袭,迁移和血管生成.
- lncRNAs在质瘤相关的免疫反应,糖解,干性和药物耐药性中起着至关重要的作用.
结论:
- lncRNA失调是结质瘤发育和恶性瘤的一个关键因素.
- 了解lncRNA功能为质瘤提供了潜在的治疗点.
- lncRNAs对于结质瘤的诊断和治疗具有重要的临床价值.
更多相关视频
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
03:18Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K